Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Chambers

Showing results (51-60 of 594) with videos related to

Pageof 60
Sort By:
Antimicrobial Agents and Chemotherapy|May 1, 1996
Treatment of Staphylococcus aureus catheter-related infection and infective endocarditis with granulocyte colony-stimulating factor in the experimental rabbit modelU Frank, H F Chambers
Journal of Molecular Medicine (Berlin, Germany)|March 17, 2015
Invasion and metastasis--recent advances and future challengesAnn F Chambers, Zena Werb
Microbial Drug Resistance (Larchmont, N.Y.)|June 27, 2020
Differential Trends in Extended-Spectrum Beta-Lactamase-Producing <i>Escherichia coli</i> Infections in Four Health Care Facilities in a Single Metropolitan Area: A Retrospective AnalysisEva Raphael, Henry F Chambers
The Journal of Infectious Diseases|June 1, 1990
Binding of beta-lactam antibiotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureusH F Chambers, M Sachdeva
Antimicrobial Agents and Chemotherapy|March 1, 1992
Characterization of penicillin-binding protein 2 of Staphylococcus aureus: deacylation reaction and identification of two penicillin-binding peptidesH F Chambers, C Miick
Antimicrobial Agents and Chemotherapy|October 1, 1989
Evaluation of cilofungin (LY121019) for treatment of experimental Candida albicans endocarditis in rabbitsA Padula, H F Chambers
Expert Review of Anti-Infective Therapy|June 6, 2007
Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin?Henry F Chambers, Sharath S Hegde
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 4, 2022
Confronting antimicrobial resistance togetherHenry F Chambers, Vance G Fowler,
Antimicrobial Agents and Chemotherapy|July 1, 1989
Methicillin-resistant staphylococci: detection methods and treatment of infectionsC J Hackbarth, H F Chambers
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Ovarian cancer biomarkers in urineAnn F Chambers, Barbara C Vanderhyden
Pageof 60

Showing results (51-60 of 594) with videos related to

Sort By:
Pageof 60
Antimicrobial Agents and Chemotherapy|May 1, 1996
Treatment of Staphylococcus aureus catheter-related infection and infective endocarditis with granulocyte colony-stimulating factor in the experimental rabbit modelU Frank, H F Chambers
Journal of Molecular Medicine (Berlin, Germany)|March 17, 2015
Invasion and metastasis--recent advances and future challengesAnn F Chambers, Zena Werb
Microbial Drug Resistance (Larchmont, N.Y.)|June 27, 2020
Differential Trends in Extended-Spectrum Beta-Lactamase-Producing <i>Escherichia coli</i> Infections in Four Health Care Facilities in a Single Metropolitan Area: A Retrospective AnalysisEva Raphael, Henry F Chambers
The Journal of Infectious Diseases|June 1, 1990
Binding of beta-lactam antibiotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureusH F Chambers, M Sachdeva
Antimicrobial Agents and Chemotherapy|March 1, 1992
Characterization of penicillin-binding protein 2 of Staphylococcus aureus: deacylation reaction and identification of two penicillin-binding peptidesH F Chambers, C Miick
Antimicrobial Agents and Chemotherapy|October 1, 1989
Evaluation of cilofungin (LY121019) for treatment of experimental Candida albicans endocarditis in rabbitsA Padula, H F Chambers
Expert Review of Anti-Infective Therapy|June 6, 2007
Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin?Henry F Chambers, Sharath S Hegde
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 4, 2022
Confronting antimicrobial resistance togetherHenry F Chambers, Vance G Fowler,
Antimicrobial Agents and Chemotherapy|July 1, 1989
Methicillin-resistant staphylococci: detection methods and treatment of infectionsC J Hackbarth, H F Chambers
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Ovarian cancer biomarkers in urineAnn F Chambers, Barbara C Vanderhyden
Pageof 60